Fludase developer NexBio raided, documents seized

Armed and flak-jacketed federal agents descended on vaccine developer NexBio at 8 a.m. yesterday. They escorted employees to parking lots and allowed them to re-enter the building only briefly 40 minutes later. An FBI spokesman wouldn't reveal the type of crime being investigated, but some 20 cardboard boxes were apparently seized. The company is developing Fludase, a powdered inhaler flu treatment. NexBio has received tens of millions of dollars in NIH grants and contracts for the effort. After operating solely with government funding, the company has recently tried to raise money from investors. Story

Suggested Articles

A Roche compound that was designed to treat rheumatoid arthritis could improve the heart's ability to repair itself, a Vanderbilt team found.

After a whirlwind year and two quick-fire raises, cancer startup Black Diamond Therapeutics has nabbed Yumanity, Merck KGaA and SR One veterans to help head up…

In this week's EuroBiotech Report, Lundbeck inks $2 billion Alder buyout, Euro biotechs raise cash and blast rocks Russian smallpox lab.